Digestive & Intestinal Remedies (Pharmacies) - Cyprus

  • Cyprus
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$12.45m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.60%, resulting in a market volume of US$14.86m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$9.81 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Cyprus is experiencing steady growth due to several factors. Customer preferences for natural and herbal remedies, as well as an increasing awareness of digestive health, are driving the demand for these products. Additionally, the local special circumstances and underlying macroeconomic factors in Cyprus contribute to the development of the market.

Customer preferences:
In recent years, there has been a shift in customer preferences towards natural and herbal remedies for digestive and intestinal issues. Consumers are becoming more conscious of the potential side effects of traditional pharmaceuticals and are seeking alternative options. This trend is evident in the growing popularity of products that contain natural ingredients such as herbs, probiotics, and enzymes. Customers are also increasingly interested in products that promote overall digestive health, such as those that support gut microbiome balance.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Cyprus is the increasing demand for probiotics. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They help restore the natural balance of bacteria in the gut and improve overall digestive health. The market for probiotic supplements and foods has been growing steadily as more consumers recognize the benefits of these products. Another trend in the market is the rising popularity of digestive enzyme supplements. Digestive enzymes help break down food and aid in the absorption of nutrients. They are particularly beneficial for individuals with digestive disorders or those who have difficulty digesting certain types of food. The demand for digestive enzyme supplements has been increasing as people seek relief from digestive discomfort and improve their overall digestion.

Local special circumstances:
Cyprus has a high prevalence of digestive disorders, including irritable bowel syndrome (IBS) and acid reflux. These conditions contribute to the demand for digestive and intestinal remedies. Additionally, the Mediterranean diet, which is rich in fruits, vegetables, and whole grains, is known for its positive effects on digestive health. The local cuisine and cultural practices in Cyprus also emphasize the importance of maintaining a healthy digestive system.

Underlying macroeconomic factors:
The economic stability and increasing disposable income in Cyprus have contributed to the growth of the Digestive & Intestinal Remedies market. As people have more purchasing power, they are willing to invest in products that promote their overall health and well-being. Furthermore, the aging population in Cyprus is also driving the demand for digestive and intestinal remedies, as older individuals are more prone to digestive issues. In conclusion, the Digestive & Intestinal Remedies market in Cyprus is developing due to customer preferences for natural and herbal remedies, the increasing awareness of digestive health, local special circumstances such as the prevalence of digestive disorders and the Mediterranean diet, and underlying macroeconomic factors such as economic stability and an aging population. The market is expected to continue growing as more consumers prioritize their digestive health and seek effective remedies.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)